Homocysteinemia and its relationship with the methylentetrahydrofolate reductase polymorphism in various ethnic groups from western Venezuela;La homocisteinemia y su relación con el polimorfismo de la metilentetrahidrofolato reductasa en varios grupos étnicos del occidente de Venezuela

Investigacion Clinica

Volumn 46, Issue 4, 2005, Pages

  Vizcaíno, Gilberto ^a   Diez Ewald, María ^a   Herrmann, Falko H ^b   Schuster, Gudrun ^b   Torres Guerra, Enrique ^a   Arteaga Vizcaíno, Melvis ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Ethnic groups; Folic acid; Homocysteine; Methylentetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID DEFICIENCY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE CONTROL; ENZYME POLYMORPHISM; ETHNIC GROUP; ETHNOLOGY; FLUORESCENCE ANALYSIS; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENETIC ASSOCIATION; GENOTYPE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MUTAGENESIS; MUTATIONAL ANALYSIS; NUTRITIONAL STATUS; PREVALENCE; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VENEZUELA; ADOLESCENT; AMERICAN INDIAN; BLOOD; GENETIC POLYMORPHISM; GENETICS; ITALY; MIDDLE AGED;

ADOLESCENT; ADULT; HOMOCYSTEINE; HUMANS; INDIANS, SOUTH AMERICAN; ITALY; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; VENEZUELA;

EID: 33244488721     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Clarke R, Daly L, Robinson K, Naughten E, Cahalane s, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Eng J Med 1991; 324: 1149-1155.
2. Dunn J, Title LM, Bata I, Johnstone DE, Kirkland SA, O'neill BJ, Zayed E, MacDonald MC, Dempsey G, Nassar B. Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset of coronary artery disease. Clin Biochem 1998; 31:95-100.
3. Goyette P, Christensen B, Rosenblatt DS, Rozen R. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene and description of five novel mutations in MTHFR. Am J Hum Genet 1996; 59:1268-1275.
4. Engbersen AM, Franken DG, Boers GJ, Stevens EM, Trijbels FJ, Blom HJ. Thermolabile 5,10 methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995; 56: 142-150.
5. Jaques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations. Circulation 1996; 93:7-9.
6. Geisel J, Hubner U, Bodis M, Schorr H, Knapp JP, Obeid R, Herrmann W. The role of genetic factors in the development of hyperhomocysteinemia. Clin Chem Lab Med 2003; 41: 1427-1434.
7. Salazar Sánchez L, Schröder W, Vizcaíno G, Pérez-Requejo JL, Jiménez G, Grimm R, Herrmann FH. The prevalence of three molecular risk factors (G20210A, C677T MTHFR, Factor V Leiden) in various ethnic groups in Costa Rica and Venezuela. Thromb Haemost 1999, 82 (suppl):275.
8. Vizcaíno G, Diez-Ewald M, Herrmann FH, Schuster G, Pérez-Requejo JL. Relationships between homocysteine, folate and vitamin B12 levels with the methylenetetrahydrofolate reductase polymorphism, in Indians from western Venezuela. Thromb Haemost 2001; 85:186-187.
9. Arruda VR, von Zuben PM, Chiparini LC, Annichino-Bizzachi JM, Costa FF. The mutation ala677val in the methylenetetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77:818-821.
10. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Borres GH, ESkes TK. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998; 128:1336-1341.
11. Van der Put NM, Van der Heuvel LP, Steegers-Theunissen PR, Trijbels FJ, Eskes TK, Mariman EC, den Heyer M, Blom HJ. Decreased methylenetetrahydrofolate reductase function due to the 677CT mutation in families with spina bifida offspring. J Mol Med 1996; 74: 691-694.
12. Abatte R, Sardi L, Pepe G, Marcucci R, Brunelli T, Prisco T, Prisco D, Fatini C, Capanni ML, Simonetti L, Gensini FG. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associate to an increased risk for coronary artery disease (CAD). Thromb Haemost 1998; 79:727-730.
13. Brattstrom L, Zhang Y, Hurtug M, Refsum H, Ostyensson S, Fransson L, Jones K, Landgren F, Brudin L, Ueland PM. A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis 1998; 141:315-319.
14. Verhoef BJ, Trip MD, Prins MH, Kastelein JJ, Reitsma PH. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. Atherosclerosis 1998; 141:161-166.
15. Scholtz CL, Odendaal HJ, Thiart R, Laubser L, Hillermann R, Delport R, Vermaak K, Kotze MJ. Analysis of two mutations in the MTHFR gene associated with mild hyperhomocysteinemia heterogeneous distribution in the South African population. S Afr Med J 2002; 92:464-467.
16. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular diseases: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-113.
17. Dekou V, Gudnason V, Hawe E, Miller GJ, Stansbie D, Humphries SE. Gene environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men. Thromb Haemost 2001; 85:67-74.
18. Amouzou EK, Chabi NW, Adjalla CE, Rodriguez-Gueant RM, Feillet F, Villaume A, Sanni A, Gueant JL. High prevalence of hyperhomocysteinemia related to folate deficiency and the 677C→T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa. Am J Clin Nutr 2004; 79: 619-624.
19. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Rush D, Schaefer EJ, Rosenberg IH. Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population. J Nutr 1996; 126:1258S-1265S.
20. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, BlocK PC, Holzgang CR, Anderson PH, Seltzer D. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 1997; 17: 1157-1162.
21. Schwartz SM, Siscovick DS, Malinow MR, Risendaal FR, Beverly BK, Hes DL, Psaty BM, Longstreth WT Jr, Koepsell TD, Raghunathan TE, Reitsma PH. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997; 96:412-417.
22. Rodríguez-Esparragón F, Hernández-Perera O, Rodríguez-Pérez JC, Anabitarte A, Díaz-Cremades JM, Lozada A, Fiuza D, Hernández E, Yunis C, Ferrario CM. The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine. Clin Exp Hypertens 2003; 25:209-220.
23. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population references ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999; 131:331-339.
24. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332:286-291.
25. Geisel J, Zimbelmann I, Schorr H, Knap JP, Bodis, Hubner U, Herrmann W. Genetics defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med 2001; 39:698-704.
26. Gemmati D, Previati M, Serino ML, Moratelli S, Guerra S, Capitani S. Forini E, Ballerini G, Scapoli GL. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocysteinemia in normal and thromboembolic subjects. Arterioscler Thromb Vasc Biol 1999; 17:1761-1767.
27. Diez-Ewald M, Vizcaino G, Zambrano-Rodríguez N. Niveles de ácido fólico y vitamina B12 en habitantes de la ciudad de Maracaibo. Invest Clin 1987; 28:75-86.
28. Carruyo-Vizcaino C, Diez-Ewald M, Vizcaino G, Arteaga-Vizcaino M. Concentración de hemoglobina y nutrientes en una población estudiantil adolescente de bajos recursos económicos. Relación con el rendimiento académico. Invest Clin 1990; 31: 189-208.
29. Diez-Ewald M, Torres Guerra E, Layrisse M, Leets I, Vizcaino G, Arteaga-Vizcaino M. Prevalence of anemia, iron, folic acid and vitamin B12 deficiency in two Bari indian communities from western Venezuela. Invest Clin 1997; 38:191-201.
30. Chandalia M, Abate N, Cabo-Chan AV Jr, Devaraj S, Jialal I, Grundy SM. Hyperhomocysteinemia in Asian Indians living in the United States. J Clin Endocrinol Metab 2003; 1089-1095.
31. Doshi SN, McDowell IFW, Moat SJ, Durrant HJ, Lewis MJ, Goodfellow J. Folic acid improves endothelial function in coronary artery disease via mechanism largely independent of homocysteine lowering. Circulation 2002; 105:22-26.
32. Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, McNulty H, Strain JJ, McPartlin J, Scott JM, Whitehead AS. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 2003; 101:2483-2488.
33. Arruda VR. Siqueira LH, Gonsalves MS, von Zuben PM, Soares MC, Menezes R, Annichino-Bizzachi JM, Costa FF. Prevalence of the mutation C677→T in the methylenetetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 1998; 78: 332-335.